Data availability
No datasets were generated or analysed during the current study.
References
Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stattermayer AF et al (2023) Histological and serological features of acute liver injury after SARS-CoV-2 vaccination. JHEP Rep 5(1):100605
Patel AH, Amin R, Lalos AT (2022) Acute liver injury and IgG4-related autoimmune pancreatitis following mRNA-based COVID-19 vaccination. Hepatol Forum 3(3):97–99
Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF et al (2022) Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol 77(5):1339–1348
Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stattermayer A, Cengiz M et al (2022) Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 76(6):1576–1586
Bril F, Al Diffalha S, Dean M, Fettig DM (2021) Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol 75(1):222–224
Kulkarni AV, Anders M, Nazal L, Ridruejo E, Efe C (2023) Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination. J Hepatol 78(2):e60–e61
Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB (2022) Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol 76(1):211–214
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T et al (2020) A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia. N Engl J Med 382(13):1219–1231
Funding
The Italian Ministry of Health (RC − 2022/2023) supported this work.
Author information
Authors and Affiliations
Contributions
S.L. collected data, performed research and wrote the original draft. R.B. analysed and interpreted the data and performed review and editing. M.M. performed histological diagnosis. F.G., E.C., A.L.F and M.D.C. performed review, and editing. I.M. critically reviewed and edited the manuscript and supervised the whole work. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Informed consent
The patient gave informed consent.
Competing interests
M.D.C. has been or is a current consultant for Celgene Corp (Bristol Myers Squibb) and received research funding from Celgene Corp (Bristol Myers Squibb). I.M. has been or is a current consultant for Bristol Myers Squibb. S.L., R.B., F.G., E.C., M.M., and A.L.F declare no competing financial interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Leoni, S., Bou-Fakhredin, R., Granata, F. et al. Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia. Ann Hematol 103, 1025–1026 (2024). https://doi.org/10.1007/s00277-023-05591-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-023-05591-x